We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
+11.09%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
AUM
$11.4B
AUM Growth
+$1.29B
Cap. Flow
+$528M
Cap. Flow %
4.63%
Top 10 Hldgs %
25.25%
Holding
2,093
New
704
Increased
330
Reduced
366
Closed
687

Top Buys

Rank Stock Value
1
PARA
Paramount Global Class B
PARA
+$75M
2
CVX icon
Chevron
CVX
+$59.9M
3
GEHC icon
GE HealthCare
GEHC
+$57.5M
4
APP icon
Applovin
APP
+$54.7M
5
OKLO
Oklo
OKLO
+$52.8M

Top Sells

Rank Stock Value
1
XEL icon
Xcel Energy
XEL
+$137M
2
META icon
Meta Platforms (Facebook)
META
+$61.8M
3
BDX icon
Becton Dickinson
BDX
+$59.9M
4
CRWV
CoreWeave
CRWV
+$57.1M
5
AAPL icon
Apple
AAPL
+$50.2M

Sector Composition

Rank Sector Weight
1 Healthcare 11.73%
2 Financials 9.81%
3 Utilities 8.63%
4 Technology 7.6%
5 Industrials 7.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HWKN icon
1226
Hawkins
HWKN
$2.46B
$338K ﹤0.01%
+2,376
New +$299K
GROY icon
1227
Gold Royalty Corp
GROY
$802M
$336K ﹤0.01%
+152,019
New +$267K
ZBRA icon
1228
Zebra Technologies
ZBRA
$17.2B
$334K ﹤0.01%
+1,084
New +$294K
HIPO icon
1229
Hippo Holdings
HIPO
$877M
$329K ﹤0.01%
11,768
-31,206
-73% -$769K
MYGN icon
1230
Myriad Genetics
MYGN
$292M
$328K ﹤0.01%
61,684
-87,009
-59% -$514K
OSG
1231
Octave Specialty Group
OSG
$204M
$327K ﹤0.01%
46,074
-46,965
-50% -$350K
SHCO
1232
DELISTED
Soho House & Co
SHCO
$326K ﹤0.01%
+44,388
New +$276K
ZD icon
1233
Ziff Davis
ZD
$1.91B
$326K ﹤0.01%
10,762
-32,232
-75% -$1.04M
PDS
1234
Precision Drilling
PDS
$1.13B
$321K ﹤0.01%
6,800
-5,300
-44% -$236K
SPRY icon
1235
ARS Pharmaceuticals
SPRY
$532M
$318K ﹤0.01%
18,217
-179,318
-91% -$2.59M
CNI icon
1236
Canadian National Railway
CNI
$77.1B
$312K ﹤0.01%
+3,000
New +$305K
SPNT icon
1237
SiriusPoint
SPNT
$2.79B
$311K ﹤0.01%
15,268
-31,525
-67% -$580K
ALSN icon
1238
Allison Transmission
ALSN
$10.8B
$310K ﹤0.01%
+3,261
New +$315K
VICR icon
1239
Vicor
VICR
$8.76B
$310K ﹤0.01%
+6,825
New +$305K
ANDE icon
1240
Andersons Inc
ANDE
$2.23B
$309K ﹤0.01%
+8,408
New +$308K
SRDX
1241
DELISTED
Surmodics
SRDX
$308K ﹤0.01%
10,379
-10,064
-49% -$290K
COCO icon
1242
Vita Coco
COCO
$3.67B
$301K ﹤0.01%
8,332
-3,945
-32% -$132K
XPEV icon
1243
XPeng
XPEV
$10.7B
$301K ﹤0.01%
+16,811
New +$328K
NCMI icon
1244
National CineMedia
NCMI
$251M
$298K ﹤0.01%
+61,565
New +$334K
SFNC icon
1245
Simmons First National
SFNC
$3.32B
$296K ﹤0.01%
15,624
-110,585
-88% -$2.08M
OUT icon
1246
Outfront Media
OUT
$5.36B
$295K ﹤0.01%
+18,055
New +$282K
PSNY icon
1247
Polestar Automotive Holding UK
PSNY
$1.87B
$295K ﹤0.01%
+9,185
New +$292K
HLIO icon
1248
Helios Technologies
HLIO
$2.44B
$289K ﹤0.01%
+8,661
New +$261K
CGAU
1249
Centerra Gold
CGAU
$4.59B
$287K ﹤0.01%
39,780
+26,680
+204% +$182K
NEWT icon
1250
NewtekOne
NEWT
$357M
$286K ﹤0.01%
25,313
+15,243
+151% +$163K

Similar funds

Michael Gelband's Q2 2025 Portfolio in Review

As of Q2 2025, Michael Gelband held 2,093 positions worth $11.4B, up 13% from $10.1B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Michael Gelband deployed $528M of net new capital in Q2 2025, opening 704 new positions and adding to 330 existing holdings. Its largest new stake was Chevron: 424,949 shares worth $60.8M.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, down from 13% a quarter earlier, followed by Financials and Utilities.

On the sell side, the largest reduction was Xcel Energy, an estimated $137M trimmed.

  • Michael Gelband's largest Q2 2025 buy was Chevron: 424,949 shares worth $60.8M.
  • Michael Gelband added most to Paramount Global Class B in Q2 2025, an estimated $75M increase.
  • Michael Gelband's biggest Q2 2025 reduction was Xcel Energy, cutting an estimated $137M.
  • Michael Gelband fully exited Meta Platforms (Facebook) in Q2 2025, selling an estimated $61.8M.
  • Michael Gelband's ten largest holdings make up 25% of its $11.4B portfolio in Q2 2025.
  • Michael Gelband opened 704 new positions and closed 687 in Q2 2025.
  • Michael Gelband's portfolio value rose 13% quarter-over-quarter to $11.4B.

Based on ExodusPoint Capital Management's 13F filing for Q2 2025, filed 13 Aug 2025.